Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Wedo Venture Partners is a venture capital firm founded in 2016, headquartered in Singapore and Beijing. The firm comprises a global team of over 10 specialized experts in science, medicine, and business, dedicated to enhancing human health through strategic investments. Wedo Venture Partners has established itself as a key player in the biotech and medical technology sectors, focusing on early-stage innovations.
Since its inception, Wedo Venture Partners has successfully built a portfolio of 30 companies, demonstrating a commitment to addressing market dislocations and cultural barriers. The firm has achieved notable milestones, including a full exit from its first fund, showcasing strong performance and a clear path to value creation. Their approach emphasizes global impact, aiming for outcomes that improve health through IPOs, acquisitions, and strategic partnerships.
Wedo Venture Partners invests primarily in the biotechnology and medical technology sectors, targeting early-stage innovations across the globe, particularly in North America, Asia, and their home bases in Singapore and China. The firm focuses on pre-seed, seed, seed-plus (extension), and Series A funding stages, providing capital to startups that are poised to disrupt the healthcare landscape.
The investment thesis of Wedo Venture Partners centers on backing entrepreneurs and scientists who confront market dislocations, cultural barriers, and geopolitical challenges. This focus allows them to identify unique opportunities that others may overlook, ultimately aiming for a global impact through their investments. The firm seeks to create value and improve health outcomes through strategic partnerships and exits.
Wedo Venture Partners has built a diverse portfolio of 30 companies, although specific names were not disclosed in the provided content. The firm has achieved significant milestones, including a full exit from its first fund, which highlights its capability to identify and nurture high-potential startups in the biotech and medtech sectors.
While the exact details of the portfolio companies remain unspecified, the firm’s focus on biotechnology and medical technology suggests a concentration on innovative solutions that address pressing health challenges. Their commitment to enhancing human health through strategic investments positions them as a valuable partner for early-stage companies in these sectors.
Xiaopeng Summer Qu - Founding Partner. Xiaopeng has extensive experience in venture capital and has led numerous successful investments in the biotech sector.
Dr. Xinhong Lim - Partner. Dr. Lim brings a wealth of knowledge in medical technology and has a strong background in scientific research.
Mu Ni - Partner. Mu has a solid track record in supporting early-stage companies and has expertise in business development.
Yun Sam Wu - Venture Partner. Yun Sam has a background in healthcare investments and provides strategic insights to portfolio companies.
Xiaomeng Marina Guo - M.D. Xiaomeng is a medical doctor with experience in clinical research and healthcare innovation.
Hui Kang - M.D. Hui has a strong background in medical technology and contributes to the firm’s investment decisions.
Leilei Wang - M.D. Leilei specializes in healthcare investments and has a keen understanding of market dynamics.
Heng Flora Li - M.D. Flora brings clinical expertise to the firm, enhancing its ability to evaluate healthcare startups.
Dong Chen - E.D. Dong has experience in venture capital and operational roles, supporting portfolio companies.
Baikuan Clint Guo - E.D. Baikuan has a background in business strategy and investment management.
Mengmeng Du - V.P. Mengmeng focuses on deal sourcing and portfolio management, ensuring alignment with the firm’s investment thesis.
To pitch Wedo Venture Partners, founders should visit their website at wedo.vc. A well-structured pitch deck should include details about the business model, market opportunity, and team qualifications. The firm values clarity and a strong narrative in pitches.
Wedo Venture Partners has recently celebrated a full exit from its first fund, demonstrating strong performance and a commitment to delivering value to its investors. This milestone highlights the firm's ability to identify and support high-potential startups in the biotech and medtech sectors.
As of 2023, the firm continues to expand its portfolio, focusing on early-stage innovations that address significant health challenges. Their ongoing efforts to bridge cultural and geopolitical gaps in the healthcare market position them as a key player in the venture capital landscape.
What are Wedo Venture Partners' investment criteria?
Wedo Venture Partners focuses on early-stage innovations in the biotechnology and medical technology sectors. They specifically look for startups that address market dislocations and cultural barriers, primarily in North America and Asia.
How can I pitch to Wedo Venture Partners?
Founders can submit their pitches through the firm's website at wedo.vc. It is advisable to include a clear overview of the business model, market opportunity, and team background in the pitch deck.
What makes Wedo Venture Partners different from other VCs?
The firm emphasizes bridging science, culture, and capital from East and West, which allows them to identify unique opportunities in the biotech and medtech sectors that may be overlooked by others.
What is the typical check size for investments?
While specific check sizes are not disclosed, Wedo Venture Partners invests at the pre-seed, seed, seed-plus, and Series A stages, indicating a focus on early-stage funding.
What is Wedo Venture Partners' post-investment involvement?
The firm aims for global impact and outcomes, planning for IPOs, acquisitions, and partnerships that create value and improve health. They likely provide ongoing support to portfolio companies to help them achieve these goals.
What is the size of Wedo Venture Partners' team?
The firm has a global team of over 10 specialized experts in science, medicine, and business, which enhances their ability to support portfolio companies effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.